Invivo Therapeutics Holdings Corp Stock OTC Bulletin Board
Equities
NVIV
US46186M1009
Advanced Medical Equipment & Technology
End-of-day quote
Other stock markets
|
||
- USD | - |
Apr. 16 | North American Morning Briefing : Powell Comments, -2- | DJ |
Apr. 02 | North American Morning Briefing : Stocks Seen -2- | DJ |
Financials (USD)
Sales 2021 | - | Sales 2022 | - | Capitalization | 4.5M |
---|---|---|---|---|---|
Net income 2021 | -9M | Net income 2022 | -10M | EV / Sales 2021 | - |
Net cash position 2021 | 17.72M | Net cash position 2022 | 15.4M | EV / Sales 2022 | - |
P/E ratio 2021 |
-1.52
x | P/E ratio 2022 |
-0.34
x | Employees | - |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 99.98% |
Managers | Title | Age | Since |
---|---|---|---|
Richard Toselli
CEO | Chief Executive Officer | 66 | 17-07-04 |
Director of Finance/CFO | 54 | 19-01-13 | |
Heather M. Hamel
LAW | General Counsel | - | 17-07-11 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 57 | 16-06-07 | |
Robert Rosenthal
BRD | Director/Board Member | 67 | 19-11-07 |
C. Merrifield
CHM | Chairman | 73 | 14-11-10 |
1st Jan change | Capi. | |
---|---|---|
+8.07% | 219B | |
+6.59% | 183B | |
+11.26% | 133B | |
+26.57% | 108B | |
+0.65% | 63.06B | |
+13.35% | 52.02B | |
-0.62% | 48.2B | |
-0.93% | 40.37B | |
+11.54% | 39.35B |
- Stock Market
- Equities
- NVIV Stock
- NVIV Stock